Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes

NCT00701350 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2010-07-21

No results posted yet for this study

Summary

The purpose of this study is to investigate the expression of protein biomarkers in cervical vaginal fluid in women with preterm premature rupture of membranes (PPROM)

Conditions

Sponsors & Collaborators

  • Obstetrix Medical Group

    collaborator INDUSTRY
  • ProteoGenix, Inc.

    lead INDUSTRY

Principal Investigators

  • Richard Porecco, MD · Obstetrix Medical Group

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00701350 on ClinicalTrials.gov